Free tools to create, edit and transform clipart
Vemurafenib Mechanism of Action: Targeting BRAF V600E in Cancer Therapy #204363 (License: Personal Use)
Search for Cliparts
About this clipart
This scientific illustration depicts the molecular mechanism of vemurafenib (PLX4032), a selective BRAF V600E inhibitor used in targeted cancer therapy. By binding to the mutated BRAF protein, vemurafenib prevents ATP-dependent phosphorylation of MEK, thereby interrupting the MAPK signaling cascade that drives uncontrolled cell division. The diagram highlights RTK activation upstream and the resulting suppression of ERK-mediated cellular proliferation.
Used in oncology educational materials, clinical guidelines, or pharmaceutical webpages explaining targeted therapy for BRAF-mutant melanoma; matches user intent seeking mechanistic understanding of vemurafenib’s action.
Related Cliparts: Learn how vemurafenib (PLX4032) selectively inhibits mutant BRAF V600E, disrupting the MAPK pathway to suppress tumor cell proliferation-key in melanoma treatment.
(view all Vemurafenib Mechanism of Action: Targeting BRAF V600E in Cancer Therapy)
Other Popular Clip Arts
Codes for Insertion
Short Link
Preview HTML
Forum BBCode
Markdown
Social Media
Use this link to share on Instagram Stories, Pinterest, etc.
WhatsApp / Telegram














